Fatty Liver Study in Older Adults
Part of Digestive system clinical trials.
This study follows older adults with fatty liver disease to understand how their metabolism changes over time and how it affects their overall health. It helps researchers learn more about the condition and its impact on the body outside the liver.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 65 years old or older.
- You must have lived in the survey area for at least 5 years.
- You must have been diagnosed with fatty liver (by ultrasound or FibroScan).
- You cannot have a major disability, mental illness, or severe heart/lung/kidney disease.
- You cannot have any type of cancer (including liver cancer).
- You cannot have had a liver or other organ transplant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a way to find liver scarring (fibrosis) early in people who have risk factors like being overweight, having type 2 diabetes, or drinking alcohol heavily. Early detection may help prevent serious liver damage.
This is a long-term study that follows adults who are being managed for fatty liver (NAFL) or NASH to learn how these conditions change over time. It may help researchers better understand what to expect and how care decisions could be improved.
This study follows people with nonalcoholic fatty liver disease to better understand the condition. It uses an MRI scan and collects body samples to help researchers study changes over time.
This study follows people with fatty liver disease (NAFLD) and a related condition (NASH) to see how it changes over time. It may help researchers understand who is most likely to worsen and what patterns show up as the disease progresses.
This study looks at people with fatty liver disease and common health issues like obesity, diabetes, high blood pressure, or abnormal cholesterol. It may help researchers understand how liver fat and heart/metabolism problems relate and how they affect health over time.
This study collects information about metabolic and unexplained (cryptogenic) liver disease and looks at “omics” tests, which are lab tests that measure patterns in blood or tissue to learn what drives the disease. It may help researchers better understand fatty liver and related serious complications, like liver scarring and liver cancer.
Hear when a new NAFLD and NASH trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.